Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119272) titled 'A prospective, observational real-world study on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with Efgartigimod' on Feb. 25.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University.
Condition:
chronic inflammatory demyelinating polyradiculoneuropathy
Recruitment Status: Recruiting
Phase: New Treatment Measure Clinical Study
Date of First Enrollment: 2025-09-30
Target Sample Size: CIDP patients treated with efgartigimod:30;
Countries of Recruitment:
China
To know more, visit https://www.ch...